Novo Nordisk Launches Wegovy Subscription Program to Improve Obesity Treatment Access and Affordability
CompanyDrug

Novo Nordisk Launches Wegovy Subscription Program to Improve Obesity Treatment Access and Affordability

Gan & Lee Pharmaceuticals' Once-Weekly Insulin GZR4 Demonstrates Superior HbA1c Reduction in Phase III Trials
CompanyDrug

Gan & Lee Pharmaceuticals’ Once-Weekly Insulin GZR4 Demonstrates Superior HbA1c Reduction in Phase III Trials

CompanyDrug

Abbisko Therapeutics Secures EMA Orphan Drug Designation for Irpagratinib in Hepatocellular Carcinoma

MicroPort Scientific Returns to Profitability as Global Access Platform Drives 78.8% Revenue Surge
Company

MicroPort Scientific Returns to Profitability as Global Access Platform Drives 78.8% Revenue Surge